Back to Rankings

INSM

InsmedD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
INSM vs peer average
31/100
INSM vs. peer average (D vs. C)
Grade spread
A 1 · B 4 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ALNY is the first available peer comparator.

Rare-disease/biotech with commercialization experience — useful for development-to-revenue transition risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerALNYAlnylam
INSM
Insmed
ALNY
Alnylam
Grade
D
C
Momentum
4
19
Value
41
58
Sentiment
100
89
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs ALNY

INSM / ALNY
Grade Position
Below peers
INSM vs. peer average (D vs. C)
31/100
Momentum
4
ALNY
Value
41
ALNY
Sentiment
100
INSM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INSM
1
ALNY
ALNY
C
60/100
-1
2
VRTX
VRTX
B
80/100
-2
3
BNTX
BioNTech SE ADR
D
40/100
Even
4
WST
West Pharmaceutical Services Inc Common
D
40/100
Even
5
UTHR
United Therapeutics Corp Common
B
80/100
-2
ALNY is the first peer returned for this comparison set.